Thermo Fisher Scientific

TMO

Market cap $234B

TMO ramps up acquisitions and product launches to drive growth, but heavy debt and currency headwinds raise questions for long-term holders.

Thermo Fisher Scientific Inc. (TMO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Thermo Fisher Scientific's pharmaceutical services business has won a number of contracts to help its customers move production from Europe or Asia to the U.S., the medical equipment maker's CEO, Marc Casper, said on Tuesday.

ROCHESTER, N.Y.--(BUSINESS WIRE)--Nalgene Outdoor today introduces Thrill & Motion, a dynamic new collection crafted for people who embrace an active, on-the-go lifestyle; whether exploring trails, chasing waves, or simply navigating everyday life. For more than 75 years, Nalgene has set the standard in durable, reusable bottles. And since pioneering the use of bold color design in the category in the early '90s, the brand continues to lead with palettes that spark individuality and adventu.

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laboratory automation at scale. The effort will leverage the NVIDIA Artificial Intelligence (AI) platform and Thermo Fisher Scientific solutions to progressively increase the automation, accuracy and speed of laboratories. The companies are working together to evolve the digital foundation that powers sci.

Thermo Fisher Scientific's number-two executive, Michel Lagarde, is leaving the life-sciences giant to pursue another opportunity.

If a recession were to hit, it's a foregone conclusion that people won't stop taking their prescriptions, and they won't cancel major medical treatments.

In the last three months of 2025, the tech sector experienced what some called a “correction”.

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the J.P. Morgan 2026 Healthcare Conference on Tuesday, January 13, 2026, at 11:15 a.m. (ET). A live webcast of the presentation will be available in the Investors section of our website, www.thermofisher.com, with a replay accessible shortly after the presentation concludes. About Thermo F.